WMS Partners’s Nymox Pharmaceutical Corp NYMX Stock Holding History

WMS Partners’s Portfolio NYMX Stock Details NYMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,000	Closed	-$3.42K	–	293
2023 Q2	$3.42K	Hold	18,000	–	–	﹤0.01%	287
2023 Q1	$6.12K	Hold	18,000	–	–	﹤0.01%	278
2022 Q4	$5.35K	Hold	18,000	–	–	﹤0.01%	274
2022 Q3	$7K	Sell	18,000 -24,000	-57%	-$9.54K	﹤0.01%	260
2022 Q2	$18K	Hold	42,000	–	–	﹤0.01%	255
2022 Q1	$53K	Buy	+42,000	New	+$64.8K	0.01%	260
2020 Q4	–	Sell	-18,000	Closed	-$44K	–	254
2020 Q3	$44K	Hold	18,000	–	–	0.01%	228
2020 Q2	$64K	Hold	18,000	–	–	0.01%	206
2020 Q1	$42K	Buy	+18,000	New	+$50.5K	0.01%	186
2019 Q4	–	Sell	-18,000	Closed	-$33K	–	234
2019 Q3	$33K	Buy	+18,000	New	+$31.5K	0.01%	222
2016 Q2	–	Sell	-21,555	Closed	-$53K	–	224
2016 Q1	$53K	Sell	21,555 -44,000	-67%	-$104K	0.01%	193
2015 Q4	$215K	Hold	65,555	–	–	0.03%	190
2015 Q3	$226K	Sell	65,555 -400	-0.6%	-$931	0.03%	185
2015 Q2	$88K	Buy	+65,955	New	+$92.1K	0.01%	269
2015 Q1	–	Sell	-66,455	Closed	-$27K	–	292
2014 Q4	$27K	Sell	66,455 -2,795	-4%	-$5.96K	﹤0.01%	210
2014 Q3	$301K	Buy	69,250 +4,588	+7%	+$22.5K	0.05%	190
2014 Q2	$320K	Buy	64,662 +1,312	+2%	+$6.75K	0.05%	185
2014 Q1	$346K	Hold	63,350	–	–	0.06%	176
2013 Q4	$384K	Buy	63,350 +4,000	+7%	+$27.3K	0.06%	156
2013 Q3	$392K	Sell	59,350 -2,000	-3%	-$13.1K	0.07%	129
2013 Q2	$311K	Buy	+61,350	New	+$311K	0.06%	163

Other funds holding NYMX

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

FCFC

First Citizens Financial Corp Mason City, Iowa $239M AUM 26.56% 1-Year Est. Return

CAM

Cubic Asset Management Boston, Massachusetts $422M AUM 29.18% 1-Year Est. Return

ODIJL

One Day In July LLC Burlington, Vermont $1.25B AUM 12.08% 1-Year Est. Return

WMS Partners's NYMX Position: Q3 2023 in Review

WMS Partners sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2023, closing a stake of 18,000 shares — an estimated $3.42K sold.

WMS Partners first reported a position in NYMX in Q2 2013 and held it in 21 quarters. The position peaked at $392K in Q3 2013. 5 funds tracked by Wall St. Rank hold NYMX as of Q3 2023.

WMS Partners reported no remaining Nymox Pharmaceutical Corp position as of Q3 2023 after selling out during the quarter.
WMS Partners sold 18,000 Nymox Pharmaceutical Corp shares in Q3 2023, an estimated $3.42K.
WMS Partners first reported a position in Nymox Pharmaceutical Corp in Q2 2013 and held it in 21 quarters.
WMS Partners's Nymox Pharmaceutical Corp position peaked at $392K in Q3 2013.
5 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2023.

Based on WMS Partners's 13F filing for Q3 2023, filed 9 Nov 2023.